Boardroom Alpha
S-1/A primary document
AIM · Amended Registration Statement (Form S-1/A) · Filed February 10, 2026

Aim Immunotech IncS-1/A exhibit

ex99-5.htm

 

Exhibit 99.5

 

FORM OF

BENEFICIAL OWNER ELECTION FORM

AIM IMMUNOTECH INC.

 

The undersigned acknowledge(s) receipt of your letter and the enclosed materials referred to therein relating to the rights offering by AIM ImmunoTech Inc., a Delaware corporation (the “Company”), of non-transferable subscription rights to purchase units, each such unit comprised of (A) one share of the Company’s Series G Convertible Preferred Stock, par value $0.01 per share (the “Preferred Stock”), with each share of Preferred Stock convertible into the number of shares of our common stock determined by dividing the $1,000 stated value per share of the Preferred Stock by a conversion price of $[       ] per share (the “Conversion Price”), and (B) 1,666 Series G Common Stock Purchase Warrants to purchase common stock expiring five years from the date of issuance (the “Warrant”). Each Warrant will be exercisable for one share of common stock at an exercise price of $[       ] per share.

 

This will instruct you whether to exercise subscription rights to purchase units distributed with respect to the shares of the common stock owned by you or participating securities held by you for the account of the undersigned, pursuant to the terms and subject to the conditions set forth in the prospectus, dated [       ] (the “Prospectus”). (Check the applicable boxes and provide all required information.)

 

Please DO NOT EXERCISE SUBSCRIPTION RIGHTS for units.
   
Please EXERCISE SUBSCRIPTION RIGHTS for units as set forth below:

 

   

No. of

Units

        Per Unit Subscription Price         Payment  
Basic Subscription Right           X   $ 1,000     =   $    
                                 
Over-Subscription Privilege           X   $ 1,000     =   $    
                                 
            Total Payment Required               $    

 

If you spoke with a broker who solicited such exercise, please indicate the name of the person you spoke with:                .

 

Payment in the following amount is enclosed $ (must match Total Payment Required above)
   
Please deduct payment from the following account maintained by you as follows:

 

Type of Account:

Account No.:

Amount to be deducted: $

 

I (we) on my (our) own behalf, or on behalf of any person(s) on whose behalf, or under whose directions, I am (we are) signing this form:

 

  irrevocably elect to purchase the number of units indicated above upon the terms and conditions specified in the Prospectus; and
     
  agree that if I (we) fail to pay for the shares I (we) have elected to purchase, the exercise will be invalid.

 

Signature:    
Name:    
Title:    
Address:    
Telephone:    

 

Date: _______, 2026

 

 

 

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer